arrow
F

Fabrizio Stocchi

Neurology
H指数:80
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early start of opicapone in Parkinson’s disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuations

帕金森病中奥匹卡朋的早期开始:来自一项合并分析的证据,该分析基于3期试验,表明对于近期出现运动波动的患者具有持续获益。

2025-12-150
OAAI
Resonant excitation of plasma wakefields with a train of relativistic particle bunches

相对论性粒子束团对等离子体尾波场的共振激发

2025-10-080
PRE
Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson’s disease: pooled analysis of patient level data from two randomized open-label studies

Correction: 奥匹卡朋治疗左旋多巴治疗的帕金森病早期“开关”现象:两项随机开放标签研究的患者层面数据合并分析

2025-08-010
OAAI
Mechanical peripheral stimulation for the treatment of gait disorders in patients with Parkinson's disease: a multi-centre, double-blind, crossover randomized controlled trial

帕金森病患者步态障碍的机械性周围神经刺激治疗:一项多中心、双盲、交叉随机对照试验

2025-04-080
OA
Resting-state electroencephalographic rhythms depend on sex in patients with dementia due to Parkinson's and Lewy Body diseases: An exploratory study

帕金森病和路易体病痴呆患者的静息态脑电图节律取决于性别: 一项探索性研究

2025-03-010
OAAI
Abnormal electroencephalographic rhythms from quiet wakefulness to light sleep in Alzheimer's disease patients with mild cognitive impairment
2025-03-010
OAAI
A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline data
2025-03-010
OAAI
Long-term, continuous, subcutaneous levodopa/carbidopa infusion with ND0612 in Parkinson's disease: 3-year outcomes from the open-label BeyoND study

长期,连续,皮下注射左旋多巴/卡比多巴输注ND0612治疗帕金森病: 开放标签BeyoND研究的3年结果

2025-03-010
PRE
Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial
2024-10-080
OAAI
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study

基因靶向试验时代基因检测的相关性: 罗斯托克帕金森病研究

BRAIN
IF11.7
2024-08-018
OAAI